Salesforce investors should watch for signs of second-half reacceleration, Jefferies says

Jefferies expects Salesforce (CRM) to report in-line fiscal Q2 results, but flagged lingering questions on whether growth can reaccelerate in the back half of the year. In a Jefferies survey of 20 partners, 70% were at or above plan for the quarter (35% at plan and 35% above). Overall, the setup looks broadly on-track with cautious implications for second-half growth.

Analysis

For CRM, the quarter itself is less important than whether management can prove that growth has stopped decelerating. In large-cap software, an in-line print with decent partner surveys often becomes a non-event unless it comes with better billings, cRPO, or a stronger FY guide; otherwise the stock can still derate because investors are paying for a reacceleration story, not just stability.

The second-order issue is competitive share migration inside the enterprise app stack. If Salesforce cannot show that AI-driven attach rates are moving the needle, budgets can drift toward Microsoft Dynamics and adjacent workflow vendors that bundle functionality more cheaply and with lower implementation friction. That hurts CRM’s multiple more than its near-term revenue line because the market is already assuming mature-growth economics; any sign that seats are being replaced by bundled platform spend would compress valuation quickly.

The partner survey is useful mainly as a guardrail against an outright miss, but it does not prove durable demand inflection. The real catalyst path is the next 1-3 months: guidance, booking trends, and commentary on pipeline conversion. Over 6-18 months, the upside case requires evidence that AI monetization expands average deal size or retention; absent that, CRM likely remains a range-bound cash-flow story rather than a rerating candidate.

Key Decisions for Investors

• No aggressive pre-earnings directional bet; the setup looks more like a volatility event than a clean fundamental inflection.
• If CRM gaps up on an in-line print without a guide raise, fade the move via short CRM / long XLK or IGV for 1-3 weeks; thesis is multiple compression once reacceleration fails to materialize.
• If management explicitly raises FY revenue or billings guidance and points to AI attach in bookings, buy the pullback in CRM with a 1-3 month horizon; that is the only path to multiple expansion.
• Watch cRPO, current RPO growth, and operating margin commentary as falsifiers: weak guide or flat bookings should keep CRM boxed in and favor competitors like MSFT Dynamics on a relative basis.